[HTML][HTML] Antibody responses to SARS-CoV-2 in patients with COVID-19
…, P Liu, J Yuan, Q Li, JL Hu, J Chen, AL Huang - Nature medicine, 2020 - nature.com
We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …
[HTML][HTML] Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
…, B Wu, XM Liu, JJ Li, JF Qiu, J Chen, AL Huang - Nature medicine, 2020 - nature.com
The clinical features and immune responses of asymptomatic individuals infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been well described. …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been well described. …
[HTML][HTML] Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
On 24 November, a new detected variant B. 1.1. 529 of SARS-CoV-2 by South Africa was
reported to WHO. After only 2 days, this variant was designated as “variant of concern”(VOC) …
reported to WHO. After only 2 days, this variant was designated as “variant of concern”(VOC) …
Longitudinal dynamics of the neutralizing antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
…, QZ Gao, GJ Zhang, CL He, LY Huang… - Clinical Infectious …, 2021 - academic.oup.com
Background Coronavirus disease 2019 (COVID-19) is a global pandemic with no licensed
vaccine or specific antiviral agents for therapy. Little is known about the longitudinal dynamics …
vaccine or specific antiviral agents for therapy. Little is known about the longitudinal dynamics …
D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). The spike (S) protein that mediates SARS-CoV-2 entry into host …
coronavirus 2 (SARS-CoV-2). The spike (S) protein that mediates SARS-CoV-2 entry into host …
A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of coronavirus disease 2019
…, Y Hu, N Tang, Y Lin, J Ren, L Huang… - The Journal of …, 2020 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel β-coronavirus,
causes severe pneumonia and has spread throughout the globe rapidly. The …
causes severe pneumonia and has spread throughout the globe rapidly. The …
Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice
…, D Wang, Y Hu, J Ren, N Tang, P Liu, Q Li, A Huang - MedRxiv, 2020 - medrxiv.org
Background We aim to investigate the profile of acute antibody response in COVID-19 patients,
and provide proposals for the usage of antibody test in clinical practice. Methods A multi-…
and provide proposals for the usage of antibody test in clinical practice. Methods A multi-…
[HTML][HTML] Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
…, L Fang, F Luo, A Jin, B Liu, N Tang, A Huang - Cellular & molecular …, 2021 - nature.com
Coronaviruses are enveloped, positive-stranded RNA viruses that contain the largest
known RNA genomes to date. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
known RNA genomes to date. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth
Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis. Treatment
of HCC is complicated by the fact that the disease is often diagnosed at an advanced …
of HCC is complicated by the fact that the disease is often diagnosed at an advanced …
[HTML][HTML] The clinical and immunological features of pediatric COVID-19 patients in China
…, DQ Wang, Y Hu, N Tang, BZ Liu, GC Wu, AL Huang - Genes & diseases, 2020 - Elsevier
In December 2019, the corona virus disease 2019 (COVID-19) caused by novel coronavirus
(SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information …
(SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. Few information …